Korea As the world around us changes, we need to change with it Marie Antonia von Schönburg has been President and Chief Executive of the Korean-German Chamber of Commerce and Industry in Seoul for 16 months. With 26 years of experience across the global network of German Chambers abroad,…
Korea D&D Pharmatech is emerging as one of Korea’s most closely watched clinical-stage biotechnology companies, built on more than two decades of research into GLP-1 biology and peptide engineering. With programmes spanning MASH, neurodegenerative diseases, fibrosis, and oral peptide therapies, the company is translating scientific innovation into clinical progress while expanding…
Korea Jungmin Rho is the Director of KOTRA – the Korea Trade-Investment Promotion Agency – and one of the organisation’s most seasoned voices on pharmaceuticals and life sciences. With more than two decades spent developing export support programmes for Korean companies across postings in Poland, Egypt, India, and Sweden, he brings…
Korea Seong-Wook Lee, CEO and founder of Rznomics, has spent more than two decades advancing trans-splicing ribozyme (TSR) technology as a novel RNA editing platform. After nearly 20 years in academia, he founded Rznomics to translate the approach into therapies for genetic and intractable diseases. With FDA-cleared clinical programmes, strategic partnerships,…
Korea Jurie Hwang is the Director of Public & International Affairs of KoreaBIO, the largest and most broadly constituted life sciences industry association in South Korea. With 650 member organisations spanning the entire value chain of the bio economy – from early-stage start-ups and venture capital firms to major conglomerates and…
Korea Dr Jeongseok Lee has served as President of the Korea Biomedicine Industry Association (KoBIA) since September 2020, backed by an outstanding 35-year career in public service and longstanding leadership in the healthcare sector. During a period marked by the unprecedented public health crisis of the COVID-19 pandemic and the significant…
Korea Kwunho Jeong, CEO of JNPMEDI, is building an integrated clinical development platform that combines proprietary software, CRO services, and biotech investment to strengthen Asia’s drug development ecosystem. A former consultant and fintech executive, he views clinical trials as fundamentally a data management challenge. Through AI, blockchain-based data integrity, and strategic…
Korea Jinhak Kim, Executive Director and President US at C&R Research, describes the company’s evolution into a global, data-driven CRO. He outlines its strategy of matching clinical trials to regions based on cost and patient access, expanding into Southeast Asia and the US, integrating AI, and supporting biotechs with end-to-end services…
Korea Switzerland and South Korea may be separated by thousands of kilometres, but their economic relationship has never been closer. Bilateral trade reached nearly USD 8 billion in 2025, pharmaceutical flows are surging, and a growing web of R&D partnerships is linking two of the world’s most innovation-intensive ecosystems. At the…
Korea Korea, already one of the world’s top clinical research destinations, is looking to boost the efficiency of its clinical trial processes even further by launching K-CThub, a one-stop digital platform for trial sponsors.* The explosion in popularity of Korean culture over the last two decades has catapulted Korea into…
Asia A whistlestop tour though the latest news from pharma in Asia, taking in the American gene sequencing giant caught in the crosshairs of the US-China tariff row, the ADC-focused Singaporean biotech getting a 187 million dollar funding boost, why the Australian regulator has rejected Eisai’s Alzheimer’s drug, the activist fund…
Korea The Top 10 Korean pharma companies ranked by 2023 sales, as compiled in the latest Citeline Scrip Asia 100. Hanmi leads the way with USD 1.14 billion in sales, a 10 percent increase on the previous year, followed by Daewoong and Boryung. Made with Visme Infographic Maker
See our Cookie Privacy Policy Here
